SAMANTHA GAMARRA: Open Payments
NPI 1720854110 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $232 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $84 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| Verity Pharmaceuticals Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| UROGEN PHARMA, INC. | 1 | $32 |
| Dendreon Pharmaceuticals LLC | 1 | $25 |
| COLOPLAST CORP | 1 | $24 |
| IMMUNITYBIO, INC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: ERLEADA, Nubeqa, ADSTILADRIN, Trelstar, ORGOVYX, ZUSDURI, PROVENGE, Luja Coude.
Industry payments across GA — which companies pay providers there.
